Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.2 USD | +2.59% | +6.18% | +22.15% |
Financials (USD)
Sales 2024 * | 4.49B | Sales 2025 * | 4.69B | Capitalization | 8.99B |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | 52M | EV / Sales 2024 * | 3.07 x |
Net Debt 2024 * | 4.77B | Net Debt 2025 * | 4.28B | EV / Sales 2025 * | 2.83 x |
P/E ratio 2024 * |
-433
x | P/E ratio 2025 * |
76.4
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Elanco Animal Health Incorporated
1 day | +2.59% | ||
1 week | +6.18% | ||
Current month | +2.94% | ||
1 month | +34.52% | ||
3 months | +12.55% | ||
6 months | +41.86% | ||
Current year | +22.15% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 63 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 67 | 19-03-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 254 M€ | +14.16% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 17 M€ | +7.25% | - | |
0.33% | 2 M€ | +9.08% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 18.2 | +2.59% | 4,942,153 |
24-06-03 | 17.74 | +0.34% | 3,549,712 |
24-05-31 | 17.68 | +0.45% | 6,101,493 |
24-05-30 | 17.6 | +1.15% | 4,998,063 |
24-05-29 | 17.4 | +1.52% | 6,041,537 |
Delayed Quote Nyse, June 04, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.15% | 8.99B | |
-12.91% | 78.43B | |
+25.50% | 3.72B | |
-2.78% | 3.19B | |
+12.16% | 1.67B | |
-25.16% | 1.24B | |
-27.23% | 1.22B | |
-18.50% | 1.07B | |
-7.57% | 968M | |
-3.13% | 901M |
- Stock Market
- Equities
- ELAN Stock